Cargando…

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

BACKGROUND: The exact risk of developing QTc-prolongation when using a combination of QTc-prolonging drugs is still unknown, making it difficult to interpret these QT drug-drug interactions (QT-DDIs). A tool to identify high-risk patients is needed to support healthcare providers in handling automat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Florine A., van der Sijs, Heleen, Becker, Matthijs L., van Gelder, Teun, van den Bemt, Patricia M. L. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376881/ https://www.ncbi.nlm.nih.gov/pubmed/32703198 http://dx.doi.org/10.1186/s12911-020-01181-3

Ejemplares similares

The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies
por: Berger, Florine A., et al.
Publicado: (2021)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients
por: Berger, Florine A., et al.
Publicado: (2021)

Physicians’ acceptance of pharmacists’ interventions in daily hospital practice
por: Zaal, Rianne J., et al.
Publicado: (2020)

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
por: van Tongeren, Justine M. Z., et al.
Publicado: (2020)

Development of a context model to prioritize drug safety alerts in CPOE systems
por: Riedmann, Daniel, et al.
Publicado: (2011)

A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency
por: Atiq, Ferdows, et al.
Publicado: (2015)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

Validation of automatic measurement of QT interval variability
por: Rijnbeek, Peter R., et al.
Publicado: (2017)

Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
por: Lu, H R, et al.
Publicado: (2008)

Managing drug-induced QT prolongation in clinical practice
por: Khatib, Rani, et al.
Publicado: (2021)

Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients
por: Egberts, Angelique, et al.
Publicado: (2017)

Does a Dose Calculator as an Add-On to a Web-Based Paediatric Formulary Reduce Calculation Errors in Paediatric Dosing? A Non-Randomized Controlled Study
por: van der Zanden, Tjitske M., et al.
Publicado: (2020)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
por: Moerlie, Ashwin R., et al.
Publicado: (2020)

Clinical effects of antiplatelet drugs and statins on D‐dimer levels
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2018)

The predictive ability of the QT response in supine-standing test for drug induced QT prolongation
por: Hochstadt, A, et al.
Publicado: (2023)

Determinants of drug prices: a systematic review of comparison studies
por: Janssen Daalen, Jules M, et al.
Publicado: (2021)

Prediction of clinically relevant adverse drug events in surgical patients
por: Bos, Jacqueline M., et al.
Publicado: (2018)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

A usability study to improve a clinical decision support system for the prescription of antibiotic drugs
por: Akhloufi, H., et al.
Publicado: (2019)

The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial
por: Bakker, T., et al.
Publicado: (2019)

Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Choi, Byung Jin, et al.
Publicado: (2021)

QT Assessment in Early Drug Development: The Long and the Short of It
por: Lester, Robert M., et al.
Publicado: (2019)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Multiple drugs: QT prolongation: case report
Publicado: (2022)

Clinically relevant drug interactions with multikinase inhibitors: a review
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2019)

Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices
por: Hassan, Dimokrat, et al.
Publicado: (2022)

Older Patients’ Compliance with Drug Storage Recommendations
por: Vlieland, Nicolaas D., et al.
Publicado: (2018)

Implementation of a Patient Questionnaire in Community Pharmacies to Improve Care for Patients Using Combined Antithrombotic Therapy: A Qualitative Study
por: van Uden, Renate C. A. E., et al.
Publicado: (2023)

A new method to calculate intra‐patient variability in tacrolimus concentrations
por: van Gelder, Teun
Publicado: (2021)

Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission
por: Van Der Luit, Charlotte D., et al.
Publicado: (2018)

Drug-related problems reported by patients with rheumatic diseases: an observational study
por: Haegens, Lex L., et al.
Publicado: (2023)

The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting
por: van der Nat, Denise J., et al.
Publicado: (2022)

Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series
por: Peeters, Laura E.J., et al.
Publicado: (2022)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

QT Dispersion and Drug-Induced Torsade de Pointes
por: Friedman, Ari, et al.
Publicado: (2021)

A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping
por: Pouls, Bart PH, et al.
Publicado: (2022)

Sex differences associated with adverse drug reactions resulting in hospital admissions
por: Hendriksen, L. C., et al.
Publicado: (2021)

Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
por: Voshaar, Marieke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_glsnm0j6r0sqjpic6d7acftptg